<?xml version="1.0" encoding="UTF-8"?>
<p>The authors also note that during the SARS outbreak, there were “case reports of considerable SARS transmission risk with the use of BiPAP to many patients over extended periods” [
 <xref ref-type="bibr" rid="CR20">20</xref>]. They concluded, in general CPAP/BiPAP should be avoided in patients with COVID-19 and should never be used outside of airborne/droplet isolation [
 <xref ref-type="bibr" rid="CR20">20</xref>]. They also note that high flow nasal cannula delivery systems may cause an increased risk of viral spread and practitioners should consider avoidance of humidified oxygen in COVID-19 patients as well. Bronchodilators should preferably be administered by metered dose inhalers [
 <xref ref-type="bibr" rid="CR20">20</xref>].
</p>
